HCBD-Pro Services
Client Subscribers
HIPN Daily Archive
No Password Required
HIPN Daily SignUp
free e-newsletter
No Password Required
Current Headlines
No Password Required
Events Calendar
No Password Required
HCBD-PRO Services
Search Companies
Search People
Search News|Events
Query News -
By Companies
By People
HR Announcements
Health Plan Industry
MailingList Rental
HCBD-EmailSend
Broadcast Email
HCBD Journalist Wire
News Distribution
Website | e-newsletter
Online Advertising
Trade Conf | Webinar
Event Promotion
Welcome <Guest>
Login
Andrea Hofelich MBA
Former VP of Communications
National Pharmaceutical Council (NPC)
Office Location:
Washington, DC USA
Company Information:
1717 Pennsylvania Ave NW
Suite 800
Washington,
DC
20006
USA
202-827-2100
HCBD Company Profile:
National Pharmaceutical Council (NPC)
Company Website:
http://www.npcnow.org
Contact the Company
In The News
NPC: The Myth of Average - Why Individual Patient Differences Matter
Employers Identify Best Practices for High-Deductible Health Plans in New Research From the National Pharmaceutical Council and Gallagher Research & Insights
National Pharmaceutical Council Appoints Sharon Phares, PhD, MPH, As Chief Scientific Officer
NPC in RealClearPolicy: Price Setting Bill Is No Panacea for Patients
View all remaining In The Stories headlines
NPC: Creating a Dialogue or Just Playing for Headlines? Third Time Isn’t the Charm for ICER’s Pricing Report
NPC: [New Research] Drug Spending Mirrors Spending on Other Health Care Services
NPC's John M. O'Brien: Health Care Stakeholders Can Learn from?Pharmacists' Patient-Centered Perspective
NPC Blog: Employers Embrace Opportunity to Increase Patient Access to Preventive Care for Chronic Conditions Through Pre-Deductible Coverage
NPC: Reference Pricing Isn’t Worth the Risk to Innovation and Patient Health
NPC Commits to Mandating COVID-19 Vaccination
NPC: Missing - Patient Input in Drug Coverage Policy
NPC and Discern Health Research found that shared decision-making and patient decision aid interventions do not always lead to reduced health care costs or utilization
NPC: Walking the Walk - Taking Needed Steps to Reduce Low-Value Care
NPC's new president and CEO Dr. John O'Brien: Let's Work Together to Improve Our Health Care System
National Pharmaceutical Council Appoints John M. O'Brien as President and CEO
NPC Blog: ICER Pricing Report - Creating a Dialogue or Just Playing for Headlines?
Pharmacy Outlook: NPC CEO Robert Dubois, NPC
NPC Blog: What’s In Your RWE Evaluation Toolbox?
The American Journal of Managed Care Adds National Pharmaceutical Council to Strategic Alliance Partnership Program
NPC: Assessing Consumer and Employer Willingness to Pay for New Medical Technologies
National Pharmaceutical Council Names Dr. Robert Dubois as Interim President and CEO
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
NPC Blog: Ready, Fire, Aim - How Not to Approach COVID Pricing Discussions
NPC in Health Affairs: It's Time to Talk COVID-19 Treatment Prices
NPC: Driving Evidence-Based Health Plan Coverage by Recognizing Gaps, Updating Practices
New NPC Report: Current Landscape - Value Assessment Frameworks
NPC Blog: Latest ICER Report Relies on Incomplete Evidence, Inadequate Analyses
NPC: Public Input Is a Key Way to Improve Value Assessment Process
NPC: Key Takeaways from a Webinar on “Amplifying the Patient Voice” in Quality Measurement
NPC Webinar: Amplifying the Patient Voice - Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs
National Pharmaceutical Council and Discern Health Outline Strategies For Improving Patient-Reported Measures in Oncology
NPC Webinar: Let’s Get Real: How Will the FDA Framework for Real-World Evidence Impact You?
NPC Case Study Shows Benefits of Engaging Employees in Health Benefit Design
NPC in Specialty Pharmacy Times: Going Below the Headlines on Health Spending in Four Steps
National Pharmaceutical Council and Duke-Margolis Center for Health Policy Announce New Health Policy Fellow
NPC: Study of U.S. Commercial Health Plans Shows Widespread Variation in Coverage and Reimbursement for Specialty Medicines
NPC's Webinar: Barriers to Paying for Value
NPC: The Impact of PBM Rebates at the Pharmacy Counter
National Pharmaceutical Council Welcomes Four Biopharmaceutical Companies as Members
National Pharmaceutical Council Launches Going Below the Surface, a Research Initiative to Explore the Different Dimensions of Health Care Spending
National Pharmaceutical Council: Understanding Real-World Evidence
NPC Request for Proposals: Beginning a Public Dialogue on Health Care Spending
National Pharmaceutical Council to Host Webinar on July 18: Same Condition, Different Costs: Should Patients Pay Different Amounts?
NPC outlines concerns with ICER/VA partnership: Will Value Assessment Frameworks Promote Health Value and Access for Veterans?
NPC, Leavitt Study: Accountable Care Organizations Have Made Progress Toward Optimizing Medication Use, But Still Face Challenges
National Pharmaceutical Council, Discern Health Outline Ways to Improve Oncology Quality Measurement in Accountable Care
Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
NPC: New Study Probes Stakeholder Attitudes on Ethics and Fairness of Cost-Sharing to Steer Appropriate Medication Use
National Pharmaceutical Council Comments on Revised ICER Value Assessment Framework
NPC: New Study Outlines Gaps, Offers Strategies to Improve Oncology Quality Measures
National Pharmaceutical Council Welcomes EMD Serono to Its Membership
NPC: Health Affairs Article Highlights Benefit of Reducing Low Value Health Care
National Pharmaceutical Council to Host Conference On Measuring Health Care Value and Impact on Patient Care
National Pharmaceutical Council Remains Engaged With the Institute for Clinical and Economic Review, Continuing Constructive Dialogue to Improve Value Assessment Frameworks
National Pharmaceutical Council and Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern California Name New Health Policy Fellow
National Pharmaceutical Council Welcomes Mallinckrodt as Its Newest Member
NPC: Data Can Offer Critical Insights, But Roadblocks to Data Access Persist
NPC Stakeholder Survey: Impact of Comparative Effectiveness Research On Health Care Decision-Making Still Three to Five Years in the Future
NPC: New Study Examines Benefits and Current Limitations of Care Pathways
Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council And the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California
NPC: Pharmaceutical Innovation’s Role in the Panorama of Health System Improvement and Population Health
Webinar: Risk-Sharing Agreements in the U.S.: Trends, Barriers and Prospects
NPC: Study Offers Solutions for Filling Gaps in Accountable Care Measure Sets
NPC | AcademyHealth: Fit for Purpose? New NPC, AcademyHealth Framework Closes Gaps Between Payer Needs and Research Answers
NPC: CMS Allows Broader Access to Taxpayer-Funded Databases, Helping Researchers Address Health Care Challenges
NPC: Improving Patient Safety Via an Electronic Drug Alert Program In an Accountable Care Environment
NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making
NPC Webinar: Is comparative effectiveness research (CER) having an impact on health care decision-making?
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council
NPC: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
Fellowship in Health Care Policy Available Through a Partnership of the National Pharmaceutical Council and Milken Institute School of Public Health at the George Washington University
Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research
NPC: Specialty Medications - Shifting the Focus From "How Much" We Spend to "How Well" We Spend
NPC: CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools
NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies
NPC: New Peer-Reviewed Study Shows Mixed Results in ACO Medication Readiness To Achieve Quality, Cost Goals
Fellowship in Policy Impact of Comparative Effectiveness Research Awarded By National Pharmaceutical Council and George Washington University
National Pharmaceutical Council Survey Shows Health Care Stakeholders Continue to Show Optimism About the Future Role of Comparative Effectiveness Research
NPC Survey of Health Care Stakeholders Indicates Cautious Optimism About Use of Comparative Effectiveness Research in Decision-Making
DIA and National Pharmaceutical Council Will Host Two-Day Conference on Comparative Effectiveness Research
NPC Conference to Address Questions on Ability to Share Health Research Findings
National Pharmaceutical Council Selects Five Research Projects for Funding
National Pharmaceutical Council Debuts Column, "From Methods to Policy," In New Journal of Comparative Effectiveness Research
AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board
National Pharmaceutical Council Welcomes Shire as Its Newest Member
NPC: Survey of Health Care Stakeholders Indicates Comparative Effectiveness Research Development Heading in Positive Direction
National Pharmaceutical Council: New Report Urges Employers, Researchers and Policy Makers to Rethink How They Measure Health Care Results
National Pharmaceutical Council Comments on Patient-Centered Outcomes Research Institute Board of Governors
NPC Welcomes GlaxoSmithKline as New Member
National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
NPC-PMC: Leaders in Healthcare to Examine Impact of Comparative Effectiveness Research on Personalized Medicine
National Pharmaceutical Council: Value-Based Insurance Design - Helping Employers Improve the Value of Health Care
Most Employers Underestimate Full Costs of Employee Health on Productivity
National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
Professional Affiliations
Director - External Communications
Alexion Pharmaceuticals
Former VP of Communications
National Pharmaceutical Council (NPC)
Generic Pharmaceutical Association (GPhA)
About Us
|
Purchase Pro
|
Contact Us
© 2006-2010 Healthcare BizDev, Inc. All rights reserved.
Privacy Policy
|
Legal Conditions